Medication info
Pabiserabeprazole 20 mg (Rabeprazole Sodium)

Pabiserabeprazole 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
HanKook Pavis Pharmaceutical Co., Ltd.
Appearance
Light yellow round enteric-coated tablet
Packaging
28 tablets/box [14 tablets/AluAlu*2]
Approval status
Active

MFDS item code 201804686 · Approved 2018.11.27 · Insurance code 621803300

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If treatment has not been successful after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of 10 mg or 20 mg twice daily may be administered orally. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, as needed, using an on-demand regimen of 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution, as hepatic function is often reduced.
Child dose
Safety for children has not been established.

Ingredients

Manufacturer
HanKook Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome.
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers, helping to alleviate symptoms of erosive or ulcerative gastroesophageal reflux disease (GERD). It is also suitable for long-term maintenance therapy of GERD and is prescribed in conjunction with antibiotics for patients with gastrointestinal ulcers infected with Helicobacter pylori. Additionally, it is used for the treatment of Zollinger-Ellison syndrome. This is a medication effective in improving various gastrointestinal disorders.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If treatment has not been successful after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of 10 mg or 20 mg twice daily may be administered orally. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, as needed, using an on-demand regimen of 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. Elderly patients Administer with caution, as hepatic function is often reduced.

Child dose

Safety for children has not been established.

Precautions

This medication should be avoided by individuals allergic to certain components or benzimidazoles. Additionally, those with allergies to penicillin-type or macrolide antibiotics used for eradicating Helicobacter pylori should also avoid this medication. It is not safe for women during pregnancy or breastfeeding. Patients with compromised liver function or the elderly should use this medication cautiously, and those with a history of allergies should also take care. If allergic symptoms like rash, hives, or itching occur during this treatment, it is important to stop taking this medication immediately and consult a physician. Regular blood tests and liver function tests should be performed, and if any abnormal signs are found, discontinuation of the medication and appropriate treatment should be initiated. Various side effects can occur in multiple systems including the heart, gastrointestinal tract, nervous system, respiratory system, and skin, so it is crucial to report any severe or unusual symptoms to healthcare providers. Long-term use may increase the risk of fractures due to osteoporosis, so caution is advised. Electrolyte imbalances such as hypomagnesemia may occur, and routine monitoring of magnesium levels is recommended for long-term users. This medication strongly inhibits gastric acid secretion, which could slightly increase the risk of bacterial infections in the stomach; if diarrhea persists, it should be discussed with a healthcare provider. There is a risk of accidents due to drowsiness while driving or operating machinery, so caution is warranted. This medication may interact with other drugs, so especially when taken with warfarin, antibiotics, or antivirals, consultation with a physician or pharmacist is necessary. It is not recommended for use during pregnancy or breastfeeding, and pregnant or breastfeeding women should definitely consult with experts. The elderly may be more susceptible to side effects due to decreased liver function, so if any abnormal symptoms occur, temporary discontinuation and consultation with a physician is advised. The safety of this medication for children has not been established, so it is advisable not to use it in children. This medication should be swallowed whole and not chewed or crushed, and it should be stored out of reach of children. Long-term use may lead to impaired absorption of vitamin B12, so periodic testing may be necessary. In cases of overdose, there is no specific antidote, so appropriate treatment and supportive care should be administered based on the symptoms.

Side effects

Rash, urticaria, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, decreased platelets, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal distension, indigestion, belching, nausea, rectal bleeding, blood in stool, anorexia, gallstones, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, neuroirritability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb weakness, sensory impairment, reduced grip strength, language confusion, staggering, delirium, disorientation, somnolence, previous history of hepatic coma in foreign patients with confusion, disorientation, somnolence, cough, pharyngitis, rhinitis, shortness of breath, asthma, nosebleed, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, lower back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuralgia, single contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color change, toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, difficulty urinating, kidney stones, uterine bleeding, polyuria, gynecomastia, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitivity reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, angioedema, hypomagnesemia, decreased platelets, decreased neutrophils, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, interstitial pneumonia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, Stevens-Johnson syndrome, increased INR, prolonged prothrombin time, bone fracture, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Storing it this way will help preserve the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablet

Package unit

28 tablets/box [14 tablets/AluAlu*2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.